Evidence map›Paper›PMID 19228891›Full record

ArticleEndocrinology2009

Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

Christopher D Green, Donald B Jump, L Karl Olson

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Significant association ofJournal of diabetes and metabolic disorders · 2021
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Nuclear receptors as drug targets for metabolic disease.Advanced drug delivery reviews · 2010
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Christopher D GreenDepartments of Physiology, Michigan State University, East Lansing, Michigan 48824-3320, USA.
Donald B Jump
L Karl Olson
Michigan State University · USOregon State University · US

Funding

DIETARY FAT REGULATION OF HEPATIC GENE EXPRESSIONR01DK043220 · NIDDK · OREGON STATE UNIVERSITY · PI JUMP, DONALD B · 1991 to 2009
$2.7M
NIDDK NIH HHS DK43220NIDDK NIH HHS R01 DK043220
6 · The paper itself

Abstract

Increased basal and loss of glucose-stimulated insulin secretion (GSIS) are hallmarks of beta-cell dysfunction associated with type 2 diabetes. It has been proposed that elevated glucose promotes insulin secretory defects by activating sterol regulatory element binding protein (SREBP)-1c, lipogenic gene expression, and neutral lipid storage. Activation of liver X receptors (LXRs) also activates SREBP-1c and increases lipogenic gene expression and neutral lipid storage but increases basal and GSIS. This study was designed to characterize the changes in de novo fatty acid and triacylglyceride (TAG) synthesis in LXR-activated beta-cells and determine how these changes contribute to elevated basal and GSIS. Treatment of INS-1 beta-cells with LXR agonist T0901317 and elevated glucose led to markedly increased nuclear localization of SREBP-1, lipogenic gene expression, de novo synthesis of monounsaturated fatty acids and TAG, and basal and GSIS. LXR-activated cells had increased fatty acid oxidation and expression of genes involved in mitochondrial beta-oxidation, particularly carnitine palmitoyltransferase-1. Increased basal insulin release from LXR-activated cells coincided with rapid turnover of newly synthesized TAG and required acyl-coenzyme A synthesis and mitochondrial beta-oxidation. GSIS from LXR-activated INS-1 cells required influx of extracellular calcium and lipolysis, suggesting production of lipid-signaling molecules from TAG. Inhibition of diacylglyceride (DAG)-binding proteins, but not classic isoforms of protein kinase C, attenuated GSIS from LXR-activated INS-1 cells. In conclusion, LXR activation in beta-cells exposed to elevated glucose concentrations increases de novo TAG synthesis; subsequent lipolysis produces free fatty acids and DAG, which are oxidized to increase basal insulin release and activate DAG-binding proteins to enhance GSIS, respectively.

Indexed as

AnimalsBenzenesulfonamidesCarnitine O-PalmitoyltransferaseCell Line, TumorCells, CulturedDisease Models, AnimalDNA-Binding ProteinsFatty AcidsFluorocarbonsGlucoseHumansHydrocarbons, FluorinatedInsulinInsulinomaInsulin-Secreting CellsInsulin SecretionBenzenesulfonamidesCarnitine O-PalmitoyltransferaseDNA-Binding ProteinsFatty AcidsFluorocarbonsGlucoseHydrocarbons, FluorinatedInsulinLiver X ReceptorsOrphan Nuclear ReceptorsReceptors, Cytoplasmic and NuclearSREBF1 protein, humanSterol Regulatory Element Binding Protein 1SulfonamidesT0901317Triglycerides

Identifiers

PMID19228891
PMCPMC2689804
OpenAlexW2162279628

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.